Fraser Craig's Form 4 filing
Windtree Therapeutics Inc (WINT) · filed Jul 26, 2022
- Accession no.
- 0001437749-22-017791
- Filed
- Jul 26, 2022, 4:37 PM ET
- Trade date
- Jul 26, 2022
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $935. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Fraser CraigCIK 0001557420 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 26, 2022 | Common Stock | PPurchaseAcquired | +2,500 | $0.374 | +$935 | 224,058 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.